Pular para o conteúdo
Menu
Mix Vale

Discovery indicates that inert gas xenon has promising potential in combating the advancement of Alzheimer’s in research

Bruna
Por 5 min de leitura
Compartilhe
Gás inerte xenônio
Foto: Gás inerte xenônio - zsv3207/ Istockphoto.com

A gas that normally doesn’t react may seem like an unusual choice for Alzheimer’s therapy, but a recent study in mice suggests that xenon, an inert substance, could be the innovation needed.

Publicidade

Xenon is part of the group of six noble gases, whose name comes from the Greek word meaning “strange”. In the medical field, it has been used as an anesthetic since the 1950s and, more recently, has been used to treat brain injuries. In addition, it is undergoing clinical trials for several other conditions, including cases of depression and panic disorder.

New research led by the University of Washington and Brigham and Women’s Hospital, both in the United States, has explored xenon’s ability to address brain changes related to Alzheimer’s disease.

Publicidade

These changes, present in the brains of all people with dementia, include the formation of clusters of amyloid and tau proteins. The condition also causes the loss of synapses, the connections between neurons that are crucial for thought, perception, movement and memory.

Another predominant feature in the brains of people with Alzheimer’s is inflammation, a body response to injury or illness that activates the immune system to restore affected tissue.

Generally, the inflammation stops once the tissue recovers. However, in Alzheimer’s disease, it persists, and activated immune reactions can, paradoxically, cause damage to healthy brain cells.

The changes described above give rise to the signs of Alzheimer’s, such as forgetfulness, disorientation and mood swings.

Although the exact cause of Alzheimer’s is unknown, a widely accepted theory suggests that the accumulation of amyloid initiates the process, which in turn generates subsequent changes. Therefore, focusing on amyloid seems to be an obvious strategy for therapy.

Publicidade

Just over two years ago, the effectiveness of one of these treatments, lecanemab, in slowing cognitive decline was announced.

The increase in protein deposits and the reduction of synapses occur over decades, and the question remains whether direct treatment of a single protein, such as amyloid or tau, would be sufficient to halt the progression of the disease or have a significant impact on all the characteristic damage.

The brain is made up of different types of cells that work together to ensure its functions. Neurons are the cells responsible for all activities, from walking and talking to thinking and breathing. Astrocytes, in turn, provide energy to neurons, in addition to offering structural support and protection.

Alzheimer's rehabilitation concept puzzle
Puzzle concept of Alzheimer’s rehabilitation – Photo: LightFieldStudios/istock

Other important cells found in the brain are microglia. They act as immune cells that help eliminate pathogens and dead cells, among other tasks. However, if they are overactive, they can generate chronic inflammation in the brain.

Microglia exhibit different states, which depend on the environment in which they are found, ranging from an inactive state to an active state. The distinction between these states can be perceived both by their morphology and, mainly, by the functions they perform. For example, microglia in an active state can help remove accumulated debris such as unwanted proteins, cells and infections.

In this recent study, researchers used mice that showed brain changes similar to those seen in Alzheimer’s disease to examine the role of microglia. A specific active state of microglia associated with inflammation was identified. By exposing mice to inhalation of xenon gas, scientists observed a change in the state of these cells.

This change in state allowed microglia to surround, engulf, and eliminate amyloid deposits. Furthermore, the function of these microglial cells was altered, so that they no longer caused inflammation.

Scientists also noticed a decrease in the number and size of amyloid deposits. All of these transformations were related to changes in the state of microglia.

But what about the other changes detected in the brains of individuals with Alzheimer’s? Research has also indicated that xenon inhalation can reduce brain atrophy, a frequent feature of the disease, and contribute to strengthening connections between neurons. In all rodents studied, markers of excessive inflammatory response were reduced.

In summary, research suggests that xenon inhalation causes active microglia to shift from an Alzheimer’s disease-like state to a pre-Alzheimer’s state. This new state favors the removal of amyloid deposits and reduces cellular messengers that trigger excessive inflammation.

New perspectives for treatment

Currently, there are no drugs that act directly on microglia to treat Alzheimer’s disease, and advances in combating amyloid accumulation have been limited. Existing drugs aimed at reducing amyloid in the brain offer a modest decrease in deposits and the rate of cognitive decline.

Although amyloid treatment tends to show improvements over time, the question remains about other changes occurring in the brain, such as tau deposits, decreased brain volume and loss of synapses. The element of value here is that, unlike previous approaches focused on a single protein, modulation of microglia by xenon demonstrates broader intervention potential, addressing multiple aspects of the disease simultaneously, which may be crucial for a more complete and long-lasting therapeutic response.

The recently released research opens up the possibility of focusing on a type of cell that has the innate ability to influence all of these damages characteristic of the disease.

The expectation is that clinical trials with healthy volunteers will begin later this year. If the results are confirmed, xenon could present a completely innovative approach to this disease that compromises cognitive functions. It would be a therapy that does not target the amyloid protein directly, but rather reconfigures the brain’s immune response to neutralize all the destructive changes of the disease. More surprising experiences have already been recorded in science.

Publicidade

Bruna Santos é colaboradora da redação do Mix Vale, portal de notícias com cobertura de Brasil e mundo. Produz conteúdo nas editorias de economia e benefícios, com foco em informação de serviço para o leitor brasileiro. Escreve e colabora para o portal desde 2024. Formação: Professora.

Notícias relacionadas

Mais lidas

  1. Ciência

    Meteoro no Nordeste: bólido cruza o céu de cinco estados às 21h34 e mobiliza buscas por fragmentos na Paraíba

  2. Caixa Econômica Federal

    Pé-de-Meia paga parcela de R$ 1.000,00 a aprovados no ensino médio de 2026 entre fevereiro e março de 2027

  3. Política

    Com obstrução parcial no intestino, Jair Bolsonaro é internado no hospital DF Star em Brasília

  4. INSS

    Recuperação da senha Gov.br pelo celular exige reconhecimento facial ou código por SMS para o Meu INSS

  5. EUA

    Terremoto em Los Angeles atinge magnitude 4,2 e causa tremores leves em Commerce na madrugada

  6. Matéria Publicitária

    MineMV é o novo jogo grátis de construir com blocos; veja como jogar e liberado para todas as idades

  7. Política

    Regulamentação da escala 5×2 pelo governo encarece cálculo da hora extra a partir de 16 de dezembro

  8. Santa Catarina

    Acidente de trânsito na SC-108 envolve carro e moto e deixa motociclista morto em São Ludgero

  9. Mundo

    Jornalista italiano Corrado Augias morre aos 91 anos; presidente da Itália lamenta a perda

  10. Loterias

    Rendimento de R$ 40 milhões da Mega-Sena 3088 chega a R$ 337 mil por mês no Tesouro Direto